PHARMACOKINETICS INVOLVED WITH KAPPA OPIOID RECEPTORS
Rattachement africain : br. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
INTRODUCTION: The receptors, members of the opioid receptor family, whose main actions involve neuroendocrine activity and pain perception, such as spinal analgesia, ventilatory depression and sedation.Although they are widely used, opioids have several adverse effects, which requires a continuous search for drugs that mitigate these consequences.Thus, among several agonists of these receptors, there are eluxadoline and R-dihydroetorphine, used as an alternative to commonly used opioids.Furthermore, such receptors are also associated with the misuse. METHODOLOGY:PubMed literature review, with the descriptors kappa AND opioid receptor in the last 5 years.Eleven scientific articles were selected, including only clinical trials in English in humans and excluding those that do not fit the pre-established objectives.RESULTS: Opioids are essential for the treatment of moderate to severe pain in oncological and perioperative patients, however, it is necessary to pay attention to chemical dependence and respiratory depression.Activation of κ and δ receptors is suggested to counteract respiratory depression induced by μ receptor activation in traditional opioids such as morphine and fentanyl.Studies of R-dihydroetorphine showed high analgesic potential, mild side effects and respiratory stability.Eluxadoline is an efficient alternative in the treatment of abdominal pain and diarrhea in Irritable Bowel Syndrome (IBS), in addition to having a lower abuse potential than other μ receptor agonists, however, the intranasal route has aversive properties, such as bad taste.There was no association of single nucleotide polymorphisms of κ receptors or δ-opioids with morphine analgesia for any pain.The use of eluxidaline must be noted, given the intestinal constipation and changes in cardiac repolarization.CONCLUSION: R-dihydroetorphine exhibited a plateau in respiratory depression but not in analgesia.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- PHARMACOKINETICS INVOLVED WITH KAPPA OPIOID RECEPTORS
- Date Crossref
- 21/09/2022
- Éditeur
- Atena Editora
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.